Document Detail


The imperative to share clinical study reports: recommendations from the Tamiflu experience.
MedLine Citation:
PMID:  22505850     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Authors:
Peter Doshi; Tom Jefferson; Chris Del Mar
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.     Date:  2012-04-10
Journal Detail:
Title:  PLoS medicine     Volume:  9     ISSN:  1549-1676     ISO Abbreviation:  PLoS Med.     Publication Date:  2012  
Date Detail:
Created Date:  2012-04-16     Completed Date:  2012-08-02     Revised Date:  2014-03-19    
Medline Journal Info:
Nlm Unique ID:  101231360     Medline TA:  PLoS Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e1001201     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiviral Agents / adverse effects,  therapeutic use
Drug Industry* / ethics
Humans
Information Dissemination*
Oseltamivir / adverse effects,  therapeutic use*
Outcome Assessment (Health Care)*
Randomized Controlled Trials as Topic*
Review Literature as Topic*
Grant Support
ID/Acronym/Agency:
10/80/01//Department of Health; T32HS019488/HS/AHRQ HHS
Chemical
Reg. No./Substance:
0/Antiviral Agents; 20O93L6F9H/Oseltamivir
Comments/Corrections
Comment In:
PLoS Med. 2012;9(4):e1001202   [PMID:  22505851 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Steroids as central regulators of organismal development and lifespan.
Next Document:  Is food insecurity associated with HIV risk? Cross-sectional evidence from sexually active women in ...